Notably, all of them are AD-associated genes and some are well-characterized drivers of this disease; for instance, APP encodes the amyloid-β peptides60, A2M is a marker of neural damage61, and APOE, CLU and NOS3 polymorphisms are risk markers of AD62. This evidence concerns the gene NOS3 and Alzheimer disease.